Identification and efficacy of longitudinal markers for survival
From MaRDI portal
Publication:5701126
DOI10.1093/biostatistics/3.1.33zbMath1133.62360OpenAlexW2124652134WikidataQ47670765 ScholiaQ47670765MaRDI QIDQ5701126
Angela Dobson, Robin Henderson, Peter J. Diggle
Publication date: 2 November 2005
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/3.1.33
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Testing in survival analysis and censored data (62N03)
Related Items (23)
Penalised logistic regression and dynamic prediction for discrete-time recurrent event data ⋮ Using the Score Test to Identify the Longitudinal Biomarker Considering Accelerate Failure Time Model with the Frailty in Survival Analysis ⋮ Explained variation for recurrent event data ⋮ Choice of Prognostic Estimators in Joint Models by Estimating Differences of Expected Conditional Kullback-Leibler Risks ⋮ Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time‐to‐event in presence of censoring and competing risks ⋮ The Identification of Potential Longitudinal Biomarkers and Measurements of Effectiveness for Biomarkers as Surrogates in Multivariate Survival Data ⋮ How the mechanism of missing data on longitudinal biomarkers influences the survival analysis ⋮ Identification of Longitudinal Biomarkers in Survival Analysis for Competing Risks Data ⋮ Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data ⋮ Quantifying the Predictive Performance of Prognostic Models for Censored Survival Data with Time-Dependent Covariates ⋮ Joint models for longitudinal and discrete survival data in credit scoring ⋮ Joint models of multivariate longitudinal outcomes and discrete survival data with INLA: an application to credit repayment behaviour ⋮ Bayesian parametric accelerated failure time spatial model and its application to prostate cancer ⋮ Evaluation of longitudinal surrogate markers ⋮ Application of trajectories from growth curve in identification of longitudinal biomarker for the multivariate survival data ⋮ Measures of prediction error for survival data with longitudinal covariates ⋮ Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach ⋮ Nonparametric Two-Sample Tests of Longitudinal Data with Termination Events ⋮ Dynamic Prediction by Landmarking in Event History Analysis ⋮ Using Frailty Models to Identify the Longitudinal Biomarkers in Survival Analysis ⋮ Identification of potential longitudinal biomarkers under the accelerated failure time model in multivariate survival data ⋮ The Method to Identify a Biomarker and to Evaluate Its Efficiency for Survival by Using the Joint Model of the Accelerate Failure Time and Longitudinal Data ⋮ Diagnostics for Joint Longitudinal and Dropout Time Modeling
This page was built for publication: Identification and efficacy of longitudinal markers for survival